Filer Snapshot

Jeff Marc Goldberg

CIK 0001703061. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

10

Latest filing

01 Dec 2022

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for AGLE. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 01 Dec 2022 for CIK 0001703061.

View source filing
Business address
C/O Akcea Therapeutics, 55 Cambridge Parkway, Ste 100, Cambridge, MA, 02142

Filer intelligence

What SEC filings say about Jeff Marc Goldberg

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for AGLE.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

AGLE

29 Nov 2022 ยท President and CEO

Latest update

What changed recently for Jeff Marc Goldberg

Ownership report updated

Latest ownership report period: 29 Nov 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

01 Dec 2022

Page type

Ownership filings

Latest period

29 Nov 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 01 Dec 2022.

SEC filing record

CIK 0001703061 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
10
First seen
13 Jul 2017
Latest filing
01 Dec 2022
Entity
Individual

Latest Filings

Showing the latest 10 of 10 SEC filings for Jeff Marc Goldberg.

4 File 001-37722

FORM 4 SUBMISSION

Filing date
01 Dec 2022
Reporting date
29 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-37722

FORM 3 SUBMISSION

Filing date
01 Dec 2022
Reporting date
29 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
26 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
03 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
09 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
02 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
17 Apr 2018
Reporting date
17 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38137

FORM 4 SUBMISSION

Filing date
04 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-38137

FORM 3 SUBMISSION

Filing date
13 Jul 2017
Reporting date
13 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .